EVAS is associated with a reduction in all-cause mortality
cxsymposium2019-09-09T09:19:47+01:00EVAS is associated with a reduction in all-cause mortality
Marc Schermerhorn, Boston, United States
EVAS is associated with a reduction in all-cause mortality
Marc Schermerhorn, Boston, United States
Podium 1st: Lutonix AV IDE interim 24 month update
Kate Steiner, Stevenage, United Kingdom
What are the special features of the CX Symposium? CX Programme Organising Board member Andrew Holden (Associate Professor of Radiology at Auckland University School of Medicine and Director of Interventional Services at Auckland City Hospital, Auckland, New Zealand) highlights the discussion, debate and “a drive to get consensus”.